SK279777B6 - Použitie riluzolu na prípravu liečiva použiteľného - Google Patents

Použitie riluzolu na prípravu liečiva použiteľného Download PDF

Info

Publication number
SK279777B6
SK279777B6 SK868-95A SK86895A SK279777B6 SK 279777 B6 SK279777 B6 SK 279777B6 SK 86895 A SK86895 A SK 86895A SK 279777 B6 SK279777 B6 SK 279777B6
Authority
SK
Slovakia
Prior art keywords
riluzole
preparation
radiorestoring
drugs
properties
Prior art date
Application number
SK868-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK86895A3 (en
Inventor
J�R�My Pratt
Jean-Marie Stutzmann
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of SK86895A3 publication Critical patent/SK86895A3/sk
Publication of SK279777B6 publication Critical patent/SK279777B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Luminescent Compositions (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SK868-95A 1993-01-07 1994-01-03 Použitie riluzolu na prípravu liečiva použiteľného SK279777B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9300073A FR2700116B1 (fr) 1993-01-07 1993-01-07 Application d'anticonvulsivants comme radioprotecteurs.
PCT/FR1994/000002 WO1994015600A1 (fr) 1993-01-07 1994-01-03 Application du riluzole comme radiorestaurateur

Publications (2)

Publication Number Publication Date
SK86895A3 SK86895A3 (en) 1995-11-08
SK279777B6 true SK279777B6 (sk) 1999-03-12

Family

ID=9442861

Family Applications (1)

Application Number Title Priority Date Filing Date
SK868-95A SK279777B6 (sk) 1993-01-07 1994-01-03 Použitie riluzolu na prípravu liečiva použiteľného

Country Status (22)

Country Link
US (1) US5656647A (ko)
EP (1) EP0678022B1 (ko)
JP (1) JP3262275B2 (ko)
KR (1) KR100298806B1 (ko)
AT (1) ATE145135T1 (ko)
AU (1) AU675281B2 (ko)
CA (1) CA2152280C (ko)
CZ (1) CZ284327B6 (ko)
DE (1) DE69400908T2 (ko)
DK (1) DK0678022T3 (ko)
ES (1) ES2093515T3 (ko)
FR (1) FR2700116B1 (ko)
GR (1) GR3021604T3 (ko)
HU (1) HU217131B (ko)
IL (1) IL108283A (ko)
MX (1) MX9400288A (ko)
NO (1) NO307204B1 (ko)
PL (1) PL309593A1 (ko)
RU (1) RU2142801C1 (ko)
SK (1) SK279777B6 (ko)
WO (1) WO1994015600A1 (ko)
ZA (1) ZA9427B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787028B1 (fr) 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
SU1109392A1 (ru) * 1983-03-01 1984-08-23 Ордена Трудового Красного Знамени Институт Химии И Химической Технологии Ан Литсср Способ получени ароматических тиопропансульфокислот или их солей
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
US4918090A (en) * 1988-01-25 1990-04-17 Warner-Lambert Company Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
US5240948A (en) * 1989-12-13 1993-08-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. 3-(3-alkylthiopropyl)benzothiazoline derivatives, their preparation and the medicament containing them
FR2662160B1 (fr) * 1990-05-18 1992-07-24 Rhone Poulenc Sante Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant.

Also Published As

Publication number Publication date
DE69400908D1 (de) 1996-12-19
US5656647A (en) 1997-08-12
EP0678022B1 (fr) 1996-11-13
DK0678022T3 (da) 1996-12-02
HU217131B (hu) 1999-11-29
DE69400908T2 (de) 1997-04-03
FR2700116A1 (fr) 1994-07-08
FR2700116B1 (fr) 1995-02-03
IL108283A0 (en) 1994-04-12
CA2152280A1 (fr) 1994-07-21
KR100298806B1 (ko) 2001-11-22
CZ284327B6 (cs) 1998-10-14
ATE145135T1 (de) 1996-11-15
JP3262275B2 (ja) 2002-03-04
NO307204B1 (no) 2000-02-28
GR3021604T3 (en) 1997-02-28
EP0678022A1 (fr) 1995-10-25
AU675281B2 (en) 1997-01-30
JPH08505377A (ja) 1996-06-11
PL309593A1 (en) 1995-10-30
RU2142801C1 (ru) 1999-12-20
ES2093515T3 (es) 1996-12-16
IL108283A (en) 1998-02-22
CZ176395A3 (en) 1995-12-13
HUT72329A (en) 1996-04-29
CA2152280C (fr) 2005-06-28
ZA9427B (en) 1994-08-11
SK86895A3 (en) 1995-11-08
KR960700053A (ko) 1996-01-19
MX9400288A (es) 1994-07-29
NO952308L (no) 1995-06-12
HU9502062D0 (en) 1995-09-28
WO1994015600A1 (fr) 1994-07-21
AU5818794A (en) 1994-08-15
NO952308D0 (no) 1995-06-12

Similar Documents

Publication Publication Date Title
RU2157205C2 (ru) Применение рилузола для лечения нейро-спида и способ получения лекарственного средства
RU2221563C2 (ru) Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона
SK279759B6 (sk) Použitie riluzolu na prípravu liečiva na liečenie
JPH041738B2 (ko)
US20040266809A1 (en) Method of treating multiple myeloma
DE3638124A1 (de) Neue pharmazeutische verwendung von ebselen
CA1166643A (en) Salt of ¬(1-benzyl-1h-indazol-3-yl)oxy| acetic acid (or bendazac) with the lysine
SK279777B6 (sk) Použitie riluzolu na prípravu liečiva použiteľného
US4563479A (en) Synergistic radiation protective pharmaceutical compositions
WO2021152467A1 (en) Combinations comprising bh3-mimetic compounds and inhibitors of early stages of autophagy for use in the treatment of non-hodgkin's b-cell lymphomas and lymphoid and/or myeloid leukemias
EP0557876B1 (de) Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation
EP3782620B1 (en) Pharmaceutical composition comprising 1,2-naphthoquinone derivative for use in preventing or treating acute myeloid or lymphoblastic leukemia
DE2124249C3 (de) Trans-2-chlor-l 1 -(3-piperazinyl- propyliden)-6Hdibenz- [b,e] -oxepin, Verfahren zu seiner Herstellung und pharmazeutisches Präparat
JPH08225447A (ja) ヒアルロン酸分解阻害剤およびヒアルロン酸分解疾患治療剤
EP0352652A2 (de) Verwendung von Imexon als Immunsuppressivum
JPH0517351A (ja) 3−オキシゲルミルプロピオン酸を主成分とする白血球減少抑制剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130103